tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Zhiqiang Shu, 19 are a BUY (79.17%), 5 are a HOLD (20.83%).
Analyst Zhiqiang Shu, carries an average stock price target met ratio of 36.36% that have a potential upside of 17.14% achieved within 51 days. Previously, Zhiqiang Shu worked at BERENBERG.
Zhiqiang Shu’s has documented 46 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 13-Sep-2023.
Analyst best performing recommendations are on IDYA (IDEAYA BIOSCIENCES).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 11/12/2021. The price target of $220 was fulfilled within 6 days with a profit of $13.6 (5.82%) receiving and performance score of 9.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Aug-2024
$8
$3.03 (60.97%)
1 years 3 months 10 days ago
(31-Mar-2025)
5/6 (83.33%)
$3.12 (63.93%)
189
Hold Since 10-Aug-2021
$5
$0.03 (0.60%)
1 years 4 months 17 days ago
(24-Feb-2025)
2/3 (66.67%)
$0.95 (23.46%)
61
Hold Since 15-Nov-2024
$6.2
1 years 4 months 17 days ago
(24-Feb-2025)
1/2 (50%)
$-0.22 (-3.43%)
4
Hold Since 29-Mar-2021
$8
$3.03 (60.97%)
1 years 6 months 4 days ago
(07-Jan-2025)
1/2 (50%)
$-1.02 (-11.31%)
15
Buy Since 12-Dec-2023
$6
1 years 6 months 25 days ago
(16-Dec-2024)
3/3 (100%)
$-3.89 (-39.33%)
160
What Year was the first public recommendation made by Zhiqiang Shu?
